Ignite Creation Date:
2024-05-06 @ 6:01 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05512780
Status:
UNKNOWN
Last Update Posted:
2022-08-23
First Post:
2022-08-22
Brief Title:
Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positiveHER2-negative Breast Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Hebei Medical University Fourth Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-08-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-10
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-22
First Submit QC Date:
August 22 2022
Study First Post Date:
2022-08-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-22
Last Update Post Date:
2022-08-23
Last Update Post Date Type:
ACTUAL